GILEAD SCIENCES, INC. Stock Repurchases 2007-2026 | GILD
Beta
What is stock repurchases?
Stock repurchases (buybacks) represent cash spent to buy back the company's own shares from the open market, returning capital to shareholders.
What is GILEAD SCIENCES, INC.'s current stock repurchases?
GILEAD SCIENCES, INC. (GILD) annual stock repurchases for 2025 was $1.92B, a 67.13% increase from 2024. GILEAD SCIENCES, INC. stock repurchases for the quarter ending March 31, 2026 was $419.0M.
What was GILEAD SCIENCES, INC.'s stock repurchases in 2024?
GILEAD SCIENCES, INC. annual stock repurchases for 2024 was $1.15B, a 15.00% increase from 2023.
What was GILEAD SCIENCES, INC.'s stock repurchases in 2023?
GILEAD SCIENCES, INC. annual stock repurchases for 2023 was $1.00B, a 28.37% decline from 2022.
What is GILEAD SCIENCES, INC.'s 5-year stock repurchases CAGR?
GILEAD SCIENCES, INC. stock repurchases grew at a compound annual growth rate (CAGR) of 3.96% from FY2020 to FY2025, going from $1.58B to $1.92B over 5 years.
Stock Repurchases History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+4.0%
FY2020
$1.58B
→
FY2025
$1.92B
07080910111213141516171819202122232425
5 years selected
Stock Repurchases History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $1.92B | +67.1% | 10-K |
| FY2024 | $1.15B | +15.0% | 10-K |
| FY2023 | $1.00B | -28.4% | 10-K |
| FY2022 | $1.40B | +155.7% | 10-K |
| FY2021 | $546.0M | -65.5% | 10-K |
| FY2020 | $1.58B | -9.5% | 10-K |
| FY2019 | $1.75B | -39.7% | 10-K |
| FY2018 | $2.90B | +204.0% | 10-K |
| FY2017 | $954.0M | -91.3% | 10-K |
| FY2016 | $11.00B | +10.0% | 10-K |
| FY2015 | $10.00B | +87.0% | 10-K |
| FY2014 | $5.35B | +819.1% | 10-K |
| FY2013 | $582.0M | -12.7% | 10-K |
| FY2012 | $667.0M | -72.0% | 10-K |
| FY2011 | $2.38B | -40.8% | 10-K |
| FY2010 | $4.02B | +302.9% | 10-K |
| FY2009 | $998.5M | -49.3% | 10-K |
| FY2008 | $1.97B | +304.0% | 10-K |
| FY2007 | $487.5M | - | 10-K |
Company: GILEAD SCIENCES, INC.Ticker: GILDSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →